Protein overexpression of c-MET has a significant impact on survival in patients with uterine cervical adenocarcinoma

被引:0
|
作者
Lee, J. Y. [1 ]
Kim, W. Y. [1 ]
Shim, S. H. [1 ]
Park, J. H. [1 ]
So, K. A. [1 ]
Kim, T. J. [1 ]
Lee, S. J. [1 ]
Park, H. K. [1 ]
机构
[1] Konkuk Univ, Sch Med, Seoul, South Korea
关键词
D O I
10.1016/j.ygyno.2020.05.274
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
386
引用
收藏
页码:180 / 181
页数:2
相关论文
共 50 条
  • [41] The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma
    Yetimalar, Mehmet Hakan
    Kilic, Derya
    Bezircioglu, Incim
    Yigit, Seyran
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2213 - 2219
  • [42] Cutoff Determination for C-met Protein Overexpression by VENTANA MET (SP44) IHC to Determine Teliso-v Eligibility in NSCLC
    Zhang, N.
    Sun, Y.
    Ansell, P. J.
    Mistry, A. T.
    Li, M. M.
    Hotson, A. G.
    Ratajczak, C. K.
    Smith, D.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S247 - S248
  • [43] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase c β (p-PKC β) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    LABORATORY INVESTIGATION, 2008, 88 : 353A - 353A
  • [44] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase cβ (p-PKCβ) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    MODERN PATHOLOGY, 2008, 21 : 353A - 353A
  • [45] Use of Beta Blockers Has No Impact on Survival of Patients With Pancreatic Ductal Adenocarcinoma
    Yang, A.
    Lucas, A. L.
    PANCREAS, 2017, 46 (10) : 1445 - 1445
  • [46] USE OF BETA BLOCKERS HAS NO IMPACT ON SURVIVAL OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA
    Yang, Anthony
    Rustgi, Sheila D.
    Lucas, Aimee L.
    GASTROENTEROLOGY, 2018, 154 (06) : S938 - S938
  • [47] MACC1 overexpression induces cisplatin resistance in lung adenocarcinoma A549 cells by activating c-Met/Akt pathway
    Zhang, Xiaokai
    Zhang, Lixin
    Jia, Chunyi
    Sun, Hongmei
    Zou, Qinguang
    Wang, Zhe
    Wang, Lei
    Qu, Mingjiang
    Zhao, Xin
    Zhao, Hui
    Wang, Bao
    Sun, Shaolin
    Wang, Qiwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 11778 - 11786
  • [48] c-Met protein overexpression and telisotuzumab vedotin efficacy by biopsy age, type, and region in the LUMINOSITY phase II study
    Bar, J.
    Baijal, S.
    Luo, A.
    Zhang, N.
    Ratajczak, C.
    Ansell, P. J.
    Lu, S.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2024, 35 : S866 - S866
  • [49] Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis
    Garcia, Stephane
    Dales, Jean-Philippe
    Charafe-Jauffret, Emmanuelle
    Carpentier-Meunier, Severine
    Andrac-Meyer, Lucile
    Jacquemier, Jocelyne
    Andonian, Claudine
    Lavaut, Marie-Noelle
    Allasia, Claude
    Bonnier, Pascal
    Charpin, Colette
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (01) : 49 - 58
  • [50] High FAK in the Background of Low c-MET and Low RON Levels Is Associated with Worse Survival in Stage I-III Colorectal Adenocarcinoma Patients
    Yoon, J-Y
    Bavi, Prashant
    Liang, Sheng-Ben
    Roehrl, Michael H.
    MODERN PATHOLOGY, 2016, 29 : 210A - 210A